Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 10/20 | 0.59 |
| ▸ | CA2 | P00918 | 10/20 | 0.59 |
| ▸ | CA9 | Q16790 | 8/20 | 0.59 |
| ▸ | CA12 | O43570 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 3/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.59 |
| ▸ | CA3 | P07451 | 2/20 | 0.59 |
| ▸ | CA4 | P22748 | 2/20 | 0.59 |
| ▸ | CA6 | P23280 | 2/20 | 0.59 |
| ▸ | CA5A | P35218 | 2/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.59 |
| ▸ | RECQL | P46063 | 2/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL285164 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL344843 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL11143885 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL9745435 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL11212246 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL9745429 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Octadecyl Sulfate SCHEMBL7532328 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL23132 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL339361 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL1191484 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114601744-B | Delivery of surfactant soluble anti-dandruff agents | 宝洁公司 | 2024-12-20 | — | — | CN | claimed |
| US-20230074959-A1 | PERSONAL CARE COMPOSITION PRESERVATIVES LEVEL OPTIMIZATION | PROCTER & GAMBLE (US) | 2023-03-09 | — | — | US | claimed |
| CN-114601744-A | Delivery of surfactant soluble antidandruff agents | 宝洁公司 | 2022-06-10 | — | — | CN | claimed |
| CN-109069370-B | Delivery of surfactant soluble agents | 宝洁公司 | 2022-06-03 | — | — | CN | claimed |
| CN-107530257-B | Delivery of surfactant soluble antidandruff agents | 宝洁公司 | 2022-03-29 | — | — | CN | claimed |
| CN-102245155-B | Personal care composition in the form of an article having a porous dissolvable solid structure | THE PROCTER & GAMBLE CO. (US) | 2015-11-25 | — | — | CN | claimed |
| CN-102325517-B | Personal care composition in the form of an article having a porous, dissolvable solid structure | PROCTER & GAMBLE | 2015-06-17 | — | — | CN | claimed |
| US-8461090-B2 | Personal care composition in the form of an article having a porous, dissolvable solid structure | THE PROCTER & GAMBLE COMPANY (US) | 2013-06-11 | — | — | US | claimed |
| US-8461091-B2 | Personal care composition in the form of an article having a porous, dissolvable solid structure | THE PROCTER & GAMBLE COMPANY (US) | 2013-06-11 | — | — | US | claimed |
| US-20100286011-A1 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | THE PROCTER & GAMBLE COMPANY | 2010-11-11 | — | — | US | claimed |
| US-20100179083-A1 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | THE PROCTER & GAMBLE COMPANY | 2010-07-15 | — | — | US | claimed |
| EP-4622618-B1 | PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN | PROCTER & GAMBLE (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4729046-A2 | COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS | The Procter & Gamble Company (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4719337-A1 | COMPOSITIONS HAVING LOW LEVELS OF SURFACTANTS AND ENHANCED DEPOSITION OF SCALP CARE ACTIVES | The Procter & Gamble Company (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4210492-B1 | DISSOLVABLE SOLID ARTICLE CONTAINING ANTI-BACTERIAL ACTIVES | PROCTER & GAMBLE (US) | 2026-04-01 | — | — | EP | disclosed |
| WO-2010077629-A2 | POROUS, DISSOLVABLE SOLID SUBSTRATES AND SURFACE RESIDENT CYCLODEXTRIN PERFUME COMPLEXES | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-08 | — | — | WO | disclosed |
| WO-2010077652-A2 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT INORGANIC PARTICULATE PERFUME COMPLEXES | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100173817-A1 | POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT STARCH PERFUME COMPLEXES | THE PROCTER & GAMBLE COMPANY | 2010-07-08 | — | — | US | disclosed |
| WO-2010077628-A2 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ATRICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100167971-A1 | POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT INORGANIC PARTICULATE PERFUME COMPLEXES | THE PROCTER & GAMBLE COMPANY | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286011-A1 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | DSG1, ASH2L, DSC1 | CA1 1448/4885CA2 1243/4885CA9 1021/4885 |
| US-20230074959-A1 | PERSONAL CARE COMPOSITION PRESERVATIVES LEVEL OPTIMIZATION | POLR1C, CUTA, MSH6 | CA1 2571/4885CA2 1112/4885CA9 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.